Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2019 | QoL in bladder cancer

Srikala Sridhar • 15 Feb 2019
GU Cancers 2019
Bladder Cancer Genitourinary Cancer

Health-related quality of life (QoL) assessments are important in evaluating the care of cancer patients. Srikala Sridhar, MD, FRCPC, of the Princess Margaret Cancer Centre, Toronto, ON, reports that QoL remains poorly standardized in bladder cancer, and stresses the need for a better way to assess QoL in order to compare the potentiality of bladder cancer drugs in clinical trials. This video was taken at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.

More from Srikala Sridhar

3:13
JAVELIN Bladder 100: duration of treatment-free interval
Srikala Sridhar • 8 Jun 2021
1:02
Maintenance therapy in urothelial carcinoma
Srikala Sridhar • 8 Jun 2021
2:01
Immune checkpoint inhibitors in urothelial bladder cancer
Srikala Sridhar • 8 Jun 2021
4:22
CheckMate 274 & EV-301: highlights in UC from ASCO GU
Srikala Sridhar • 15 Feb 2021

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals